A carregar...
Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission
BACKGROUND: To evaluate the efficacy and safety of treating HBV-positive mothers with telbivudine in early and middle pregnancy to prevent mother-to-infant HBV transmission. METHODS: The subject population comprised pregnant women with chronic hepatitis B (CHB; n = 188) from January 2013 to June 201...
Na minha lista:
| Publicado no: | BMC Gastroenterol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5390436/ https://ncbi.nlm.nih.gov/pubmed/28407735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-017-0608-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|